{"id":300,"date":"2023-09-07T16:14:27","date_gmt":"2023-09-07T16:14:27","guid":{"rendered":"https:\/\/www.vdh.virginia.gov\/naloxone\/?page_id=300"},"modified":"2026-04-02T17:14:53","modified_gmt":"2026-04-02T17:14:53","slug":"naloxone-distribution-to-community-partners","status":"publish","type":"page","link":"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/","title":{"rendered":"Naloxone Distribution to Community Partners"},"content":{"rendered":"<div id=\"pl-300\"  class=\"panel-layout\" ><div id=\"pg-300-0\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-300-0-0\"  class=\"panel-grid-cell\" ><div id=\"panel-300-0-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"0\" ><div id=\"sub-nav\" class=\"panel-widget-style panel-widget-style-for-300-0-0-0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><a href=\"#Harm-Reduction-Test-Strips\">Harm Reduction Test Strips<\/a> <a href=\"#Naloxone-and-Test-Strips\">Order Naloxone and Test Strips<\/a> <a href=\"https:\/\/www.vdh.virginia.gov\/naloxone\/quarterly-naloxone-distribution-newsletters\/\">Naloxone Distribution Newsletters<\/a><\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"panel-300-0-0-1\" class=\"so-panel widget widget_sow-editor\" data-index=\"1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<h2><span class=\"TextRun SCXW70811199 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW70811199 BCX8\" data-ccp-parastyle=\"heading 2\">High-Impact (<\/span><span class=\"NormalTextRun SCXW70811199 BCX8\" data-ccp-parastyle=\"heading 2\">No-Cost<\/span><span class=\"NormalTextRun SCXW70811199 BCX8\" data-ccp-parastyle=\"heading 2\">)<\/span><span class=\"NormalTextRun SCXW70811199 BCX8\" data-ccp-parastyle=\"heading 2\"> Naloxone Distribution\u00a0<\/span><\/span><span class=\"EOP SCXW70811199 BCX8\" data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><\/h2>\n<p>Virginia Department of Health (VDH) and the <a href=\"https:\/\/dbhds.virginia.gov\/\">Virginia Department of Behavioral Health and Developmental Services<\/a> (DBHDS) share the common goal of increasing naloxone access for all Virginians. Due to limited resources, VDH is prioritizing high-risk individuals to receive no-cost naloxone. High-risk individuals include people who use drugs (PWUD), family members, friends or coworkers of PWUD and people who work directly with PWUD.<\/p>\n<p>The following organization types are eligible to obtain naloxone at no-cost from VDH. Eligibility criteria are subject to change.<\/p>\n<ul>\n<li><span data-contrast=\"none\">Authorized <\/span><a href=\"https:\/\/www.vdh.virginia.gov\/disease-prevention\/chr\/\"><span data-contrast=\"none\">comprehensive harm reduction sites<\/span><\/a><\/li>\n<li><span data-contrast=\"none\">C<\/span><span data-contrast=\"none\">ommunity services boards<\/span><\/li>\n<li><span data-contrast=\"none\">L<\/span><span data-contrast=\"none\">ocal health<\/span> <span data-contrast=\"none\">departments<\/span><\/li>\n<li><span data-contrast=\"none\">First responders<\/span><span data-ccp-props=\"{&quot;335557856&quot;:16777215,&quot;335559738&quot;:264,&quot;335559739&quot;:396}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"none\">R<\/span><span data-contrast=\"none\">eentry programs<\/span><span data-ccp-props=\"{&quot;335557856&quot;:16777215,&quot;335559738&quot;:264,&quot;335559739&quot;:396}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"none\">K-12 public school divisions\u00a0\u00a0<\/span><span data-ccp-props=\"{&quot;335557856&quot;:16777215,&quot;335559738&quot;:264,&quot;335559739&quot;:396}\">\u00a0<\/span><\/li>\n<li>Public universities (campus recovery programs)<\/li>\n<li>High-impact community partners<\/li>\n<\/ul>\n<p><span class=\"NormalTextRun SCXW197211596 BCX8\">The Division of Pharmacy Services <\/span><span class=\"NormalTextRun SCXW197211596 BCX8\">currently ships<\/span> <span class=\"NormalTextRun SCXW197211596 BCX8\">over-the-counter<\/span><span class=\"NormalTextRun SCXW197211596 BCX8\"> (OTC) 4mg naloxone nasal spray, <span class=\"TextRun SCXW31568664 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW31568664 BCX8\">prescription 8mg<\/span><span class=\"NormalTextRun SCXW31568664 BCX8\"> naloxone nasal spray, and <\/span><\/span><span class=\"TrackChangeTextInsertion TrackedChange SCXW31568664 BCX8\"><span class=\"TextRun SCXW31568664 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW31568664 BCX8\">prescription <\/span><\/span><\/span><span class=\"TrackChangeTextInsertion TrackedChange SCXW31568664 BCX8\"><span class=\"TextRun SCXW31568664 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW31568664 BCX8\">intramuscular (IM) naloxone<\/span><\/span><\/span><span class=\"TextRun SCXW31568664 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW31568664 BCX8\"> to <\/span><\/span><span class=\"TrackChangeTextInsertion TrackedChange SCXW31568664 BCX8\"><span class=\"TextRun SCXW31568664 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW31568664 BCX8\">eligible <\/span><\/span><\/span><span class=\"TextRun SCXW31568664 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW31568664 BCX8\">partners<\/span><\/span><\/span>. <span class=\"NormalTextRun DefaultHighlightTransition SCXW152017762 BCX8\">Prescription naloxone must continue to be<\/span><span class=\"NormalTextRun DefaultHighlightTransition SCXW152017762 BCX8\"> dispense<\/span><span class=\"NormalTextRun DefaultHighlightTransition SCXW152017762 BCX8\">d<\/span> <span class=\"NormalTextRun DefaultHighlightTransition SCXW152017762 BCX8\">in <\/span><span class=\"NormalTextRun DefaultHighlightTransition SCXW152017762 BCX8\">accordance with<\/span><span class=\"NormalTextRun DefaultHighlightTransition SCXW152017762 BCX8\"> the <\/span><a href=\"https:\/\/www.dhp.virginia.gov\/media\/dhpweb\/docs\/pharmacy\/guidance\/110-44.pdf\">Virginia Board of Pharmacy Naloxone protocol<\/a>, which includes utilizing the <a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/08\/Statewide-Standing-Order-for-Naloxone-and-Other-Opioid-Reversal-Agents-1.20.26.pdf\">Statewide Standing Order for Naloxone and Other Opioid Reversal Agents.<\/a><\/p>\n<p><strong>Additional Resources:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/01\/No-Cost-Naloxone-Distribution-Program_2025.pdf\">No-Cost Naloxone Distribution Program One-Pager<\/a> (January 2025)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/01\/General-MOU-Requirements-for-Non-LHD-Partners_2025.pdf\">General Naloxone Agreement Requirements for Partners<\/a> (January 2025)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/08\/Prescription-vs.-Over-the-Counter-Naloxone-8.6.24.pdf\">Prescription vs. Over-the-Counter Naloxone Requirements<\/a> (August 2024)<\/li>\n<\/ul>\n<\/div>\n<\/div><\/div><div id=\"panel-300-0-0-2\" class=\"so-panel widget widget_sow-accordion\" data-index=\"2\" ><div id=\"partners-accordion\" class=\"panel-widget-style panel-widget-style-for-300-0-0-2\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-accordion so-widget-sow-accordion-default-30a6380c8bef-300\"\n\t\t\t\n\t\t><div>\n\t<div class=\"sow-accordion\">\n\t\t\t<div class=\"sow-accordion-panel\n\t\t\t\t\t\"\n\t\t\t\tdata-anchor-id=\"expanded-access-at-cost-naloxone-distribution\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header-container\" role=\"heading\" aria-level=\"2\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header\" tabindex=\"0\" role=\"button\" id=\"accordion-label-expanded-access-at-cost-naloxone-distribution\" aria-controls=\"accordion-content-expanded-access-at-cost-naloxone-distribution\" aria-expanded=\"false\">\n\t\t\t\t\t\t<div class=\"sow-accordion-title sow-accordion-title-icon-left\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tExpanded Access (At-Cost) Naloxone Distribution\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"sow-accordion-open-close-button\">\n\t\t\t\t\t\t\t<div class=\"sow-accordion-open-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf218;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"sow-accordion-close-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf209;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\n\t\t\t<div\n\t\t\t\tclass=\"sow-accordion-panel-content\"\n\t\t\t\trole=\"region\"\n\t\t\t\taria-labelledby=\"accordion-label-expanded-access-at-cost-naloxone-distribution\"\n\t\t\t\tid=\"accordion-content-expanded-access-at-cost-naloxone-distribution\"\n\t\t\t\tstyle=\"display: none;\"\t\t\t>\n\t\t\t\t<div class=\"sow-accordion-panel-border\">\n\t\t\t\t\t<h3 aria-level=\"2\"><span data-contrast=\"none\">What is Expanded Access?\u202f<\/span><span data-ccp-props=\"{&quot;134245418&quot;:true,&quot;134245529&quot;:true,&quot;335559738&quot;:40,&quot;335559739&quot;:0}\">\u00a0<\/span><\/h3>\n<p><span data-contrast=\"none\">Expanded Access is an extension of the High-Impact (No-Cost) Naloxone Distribution Program. This program extension provides over-the-counter (OTC) naloxone 4mg nasal spray to organizations whose intended use of naloxone does not qualify for the no-cost naloxone.\u00a0<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559685&quot;:0,&quot;335559737&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><span data-contrast=\"none\">VDH provides naloxone to Expanded Access partners at cost, inclusive of the cost of the drug, processing and shipping fees. Eligible partners include:\u202f\u202f<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559685&quot;:0,&quot;335559737&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li><span data-contrast=\"none\">Institutions of higher education\u202f<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"none\">Local government jurisdictions (counties and independent cities)\u202f<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"none\">Private K-12 schools\u202f<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"none\">State agencies\u202f<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n<p><span data-contrast=\"none\">While High-Impact Partners are restricted to providing no-cost naloxone solely to high-risk individuals, Expanded Access partners are not limited by these eligibility restrictions when distributing purchased naloxone. High-Impact Partners may also participate in the Expanded Access extension, allowing them to access no-cost naloxone for high-risk individuals <\/span><i><span data-contrast=\"none\">and <\/span><\/i><span data-contrast=\"none\">purchase naloxone for individuals who may not be at the highest risk of overdose.\u202f<\/span><span data-ccp-props=\"{&quot;134233117&quot;:false,&quot;134233118&quot;:false,&quot;201341983&quot;:0,&quot;335551550&quot;:1,&quot;335551620&quot;:1,&quot;335559685&quot;:0,&quot;335559737&quot;:0,&quot;335559738&quot;:0,&quot;335559739&quot;:240,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<p><strong>Apply for an Expanded Access agreement: <a href=\"https:\/\/redcap.vdh.virginia.gov\/redcap\/surveys\/?s=HN9LCFDR7TK3ERPW\">Naloxone Expanded Access Registration and Order Form<\/a>\u00a0<\/strong><\/p>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div>\n<\/div>\n<\/div><\/div><\/div><div id=\"panel-300-0-0-3\" class=\"so-panel widget widget_sow-editor\" data-index=\"3\" ><div class=\"text-box panel-widget-style panel-widget-style-for-300-0-0-3\" id=\"Harm-Reduction-Test-Strips\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t><h3 class=\"widget-title\">Harm Reduction Test Strips\u00a0<\/h3>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p>Local Health Departments, Community Service Boards, Authorized Comprehensive Harm Reduction sites, Community-Based Organizations, and Reentry Programs are eligible for no-cost naloxone, fentanyl test strips, xylazine test strips, benzodiazepine test strips, nitazene test strips, and medetomidine test strips to distribute to high-risk members of the local community.<\/p>\n<p><strong>Additional Resources:\u00a0<\/strong><\/p>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/02\/Harm-Reduction-Test-Strip-Instructions_June-2025.pdf\" target=\"_blank\" rel=\"noopener\">Test Strip Instructions for Harm Reduction<\/a>\u00a0 (English)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/02\/Fentanyl-Xylazine-and-Benzodiazepine-Test-Strips_es-2.pdf\" target=\"_blank\" rel=\"noopener\">Test Strip Instructions for Harm Reduction<\/a>\u00a0 (Spanish)<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/3\/2023\/07\/Reference-Guide-Xylazine-Test-Strips.pdf\" target=\"_blank\" rel=\"noopener\">Xylazine Test Strip Instructions<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/3\/2023\/07\/Reference-Guide-Benzodiazepine-Test-Strips.pdf\" target=\"_blank\" rel=\"noopener\">Benzodiazepine Test Strip Instructions<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/05\/Nitazene-Test-Strip-Instructions-ENG_ES_FR.pdf\">Nitazene Test Strip Instructions<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/Medetomidine-Test-Strip-Instructions-2.pdf\">Medetomidine Test Strip Instructions<\/a><\/li>\n<li><a href=\"https:\/\/youtu.be\/hwF6986Sd3o\">Video Instructions for Harm Reduction Test Strips<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/div>\n<\/div><\/div><\/div><div id=\"panel-300-0-0-4\" class=\"so-panel widget widget_sow-accordion panel-last-child\" data-index=\"4\" ><div id=\"partners-accordion\" class=\"panel-widget-style panel-widget-style-for-300-0-0-4\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-accordion so-widget-sow-accordion-default-9500ea39ad98-300\"\n\t\t\t\n\t\t><div>\n\t<div class=\"sow-accordion\">\n\t\t\t<div class=\"sow-accordion-panel\n\t\t\t\t\t\"\n\t\t\t\tdata-anchor-id=\"first-responders\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header-container\" role=\"heading\" aria-level=\"2\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header\" tabindex=\"0\" role=\"button\" id=\"accordion-label-first-responders\" aria-controls=\"accordion-content-first-responders\" aria-expanded=\"false\">\n\t\t\t\t\t\t<div class=\"sow-accordion-title sow-accordion-title-icon-left\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tFirst Responders\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"sow-accordion-open-close-button\">\n\t\t\t\t\t\t\t<div class=\"sow-accordion-open-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf218;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"sow-accordion-close-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf209;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\n\t\t\t<div\n\t\t\t\tclass=\"sow-accordion-panel-content\"\n\t\t\t\trole=\"region\"\n\t\t\t\taria-labelledby=\"accordion-label-first-responders\"\n\t\t\t\tid=\"accordion-content-first-responders\"\n\t\t\t\tstyle=\"display: none;\"\t\t\t>\n\t\t\t\t<div class=\"sow-accordion-panel-border\">\n\t\t\t\t\t<p><img decoding=\"async\" class=\"accordion-icon\" src=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2023\/09\/first-responder.svg\" alt=\"First Responders\" \/>First responders, including <strong>law enforcement, fire service organizations, licensed emergency medical services (EMS) agencies, correctional facilities, <span class=\"NormalTextRun SCXW192708017 BCX8\">Department of Juve<\/span><span class=\"NormalTextRun SCXW192708017 BCX8\">nile<\/span><span class=\"NormalTextRun SCXW192708017 BCX8\"> Justice, state or regional probation and parole, <\/span>and local and regional jails<\/strong> are eligible for no-cost naloxone from VDH.<\/p>\n<p><strong>Additional Resources:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/05\/First-responder-handout-1.pdf\">Community Partner Resource Guide for First Responders<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/04\/Mail-to-Home-Naloxone-Webinar-02.19.2025-1.pdf\">Mail-to-Home Naloxone Webinar for First Responders<\/a> - February 19, 2025<\/li>\n<\/ul>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t<div class=\"sow-accordion-panel\n\t\t\t\t\t\"\n\t\t\t\tdata-anchor-id=\"high-impact-community-partners\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header-container\" role=\"heading\" aria-level=\"2\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header\" tabindex=\"0\" role=\"button\" id=\"accordion-label-high-impact-community-partners\" aria-controls=\"accordion-content-high-impact-community-partners\" aria-expanded=\"false\">\n\t\t\t\t\t\t<div class=\"sow-accordion-title sow-accordion-title-icon-left\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tHigh-Impact Community Partners\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"sow-accordion-open-close-button\">\n\t\t\t\t\t\t\t<div class=\"sow-accordion-open-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf218;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"sow-accordion-close-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf209;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\n\t\t\t<div\n\t\t\t\tclass=\"sow-accordion-panel-content\"\n\t\t\t\trole=\"region\"\n\t\t\t\taria-labelledby=\"accordion-label-high-impact-community-partners\"\n\t\t\t\tid=\"accordion-content-high-impact-community-partners\"\n\t\t\t\tstyle=\"display: none;\"\t\t\t>\n\t\t\t\t<div class=\"sow-accordion-panel-border\">\n\t\t\t\t\t<p><img decoding=\"async\" class=\"accordion-icon\" src=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2023\/09\/earlyUsage.svg\" alt=\"High-Priority Community Partners\" \/>High-impact community partners include treatment and recovery centers, rehabilitation facilities, homeless service providers, and community-based organizations that serve high-risk populations. High-impact community partners are eligible for no-cost naloxone from VDH to dispense to high-risk individuals. These community partners can apply for a naloxone agreement with VDH using the steps below.<\/p>\n<p>Prior to accessing no-cost naloxone from VDH, high-impact community partners must complete one of the following training requirements:<\/p>\n<ol>\n<li>Online or in-person training in <a href=\"https:\/\/dbhds.virginia.gov\/behavioral-health\/substance-abuse-services\/revive\/\">REVIVE! Opioid Overdose and Naloxone Education<\/a> program, a course that teaches people how to respond to an opioid overdose and administer naloxone, or<\/li>\n<li>Online training in harm reduction education and counseling, which provides techniques for providing education in a short, concise manner and to provide one-on-one harm reduction counseling.<\/li>\n<\/ol>\n<p><strong>Additional Resources:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2023\/11\/Naloxone-Flowchart-for-Community-Partners.pdf\" target=\"_blank\" rel=\"noopener\">Naloxone Process Flowchart for Community Partners<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2023\/12\/Naloxone-Guidance-\u2013-Specialty-Dockets.pdf\">Naloxone Guidance for Specialty Dockets<\/a><\/li>\n<\/ul>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t<div class=\"sow-accordion-panel\n\t\t\t\t\t\"\n\t\t\t\tdata-anchor-id=\"lhds-csbs-chrs\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header-container\" role=\"heading\" aria-level=\"2\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header\" tabindex=\"0\" role=\"button\" id=\"accordion-label-lhds-csbs-chrs\" aria-controls=\"accordion-content-lhds-csbs-chrs\" aria-expanded=\"false\">\n\t\t\t\t\t\t<div class=\"sow-accordion-title sow-accordion-title-icon-left\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tLHDs, CSBs, CHRs\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"sow-accordion-open-close-button\">\n\t\t\t\t\t\t\t<div class=\"sow-accordion-open-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf218;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"sow-accordion-close-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf209;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\n\t\t\t<div\n\t\t\t\tclass=\"sow-accordion-panel-content\"\n\t\t\t\trole=\"region\"\n\t\t\t\taria-labelledby=\"accordion-label-lhds-csbs-chrs\"\n\t\t\t\tid=\"accordion-content-lhds-csbs-chrs\"\n\t\t\t\tstyle=\"display: none;\"\t\t\t>\n\t\t\t\t<div class=\"sow-accordion-panel-border\">\n\t\t\t\t\t<p><span data-contrast=\"none\">Local health departments (LHDs), community service boards (CSBs), and authorized comprehensive harm reduction sites (CHRs) are eligible to order Kloxxado (naloxone) 8mg nasal spray in addition to the naloxone 4mg nasal spray.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/p>\n<ul>\n<li><span data-contrast=\"none\">Kloxxado 8mg nasal spray is U.S. Food and Drug Administration (FDA) approved as a prescription opioid reversal agent medication. It is the only form of higher-dose naloxone nasal spray. One dose of Kloxxado is equivalent to two doses of naloxone 4 mg nasal spray, which is the primary opioid reversal agent medication that VDH has provided to partners prior to September 2024. <\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"none\">Kloxxado 8mg is currently a <\/span><b><span data-contrast=\"none\">prescription<\/span><\/b><span data-contrast=\"none\"> medication. If dispensing to an individual pursuant to the <\/span><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/08\/Statewide-Standing-Order-for-Naloxone-and-Other-Opioid-Reversal-Agents-1.20.26.pdf\"><span data-contrast=\"none\">Statewide Standing Order for Naloxone and Other Opioid Reversal Agents<\/span><\/a><span data-contrast=\"none\">, the authorized dispenser must adhere to the <\/span><a href=\"https:\/\/www.dhp.virginia.gov\/media\/dhpweb\/docs\/pharmacy\/guidance\/110-44.pdf\"><span data-contrast=\"none\">Virginia Board of Pharmacy Naloxone Protocol<\/span><\/a><span data-contrast=\"none\">, including appropriately labeling the medication and record keeping of dispensations.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<li><span data-contrast=\"none\">LHDs, CSBs, and Authorized CHRs can order Kloxxado 8mg through the same ordering platform that you currently use to order naloxone and test strips.<\/span><span data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559739&quot;:0,&quot;335559740&quot;:240}\">\u00a0<\/span><\/li>\n<\/ul>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t<div class=\"sow-accordion-panel\n\t\t\t\t\t\"\n\t\t\t\tdata-anchor-id=\"public-k-12-school-divisions\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header-container\" role=\"heading\" aria-level=\"2\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header\" tabindex=\"0\" role=\"button\" id=\"accordion-label-public-k-12-school-divisions\" aria-controls=\"accordion-content-public-k-12-school-divisions\" aria-expanded=\"false\">\n\t\t\t\t\t\t<div class=\"sow-accordion-title sow-accordion-title-icon-left\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tPublic K-12 School Divisions\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"sow-accordion-open-close-button\">\n\t\t\t\t\t\t\t<div class=\"sow-accordion-open-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf218;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"sow-accordion-close-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf209;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\n\t\t\t<div\n\t\t\t\tclass=\"sow-accordion-panel-content\"\n\t\t\t\trole=\"region\"\n\t\t\t\taria-labelledby=\"accordion-label-public-k-12-school-divisions\"\n\t\t\t\tid=\"accordion-content-public-k-12-school-divisions\"\n\t\t\t\tstyle=\"display: none;\"\t\t\t>\n\t\t\t\t<div class=\"sow-accordion-panel-border\">\n\t\t\t\t\t<p><img decoding=\"async\" class=\"accordion-icon\" src=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2023\/09\/schools.svg\" alt=\"K-12 Schools\" \/><\/p>\n<p>The Statewide Standing Order for Naloxone and Other Opioid Reversal Agents is available for public and private schools. Public K-12 schools are eligible for no-cost naloxone through VDH. Private schools may purchase OTC naloxone or email <a href=\"mailto:opioidreversal@vdh.virginia.gov\">opioidreversal@vdh.virginia.gov<\/a> for assistance.<\/p>\n<p><span class=\"steps-button\"><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/08\/Statewide-Standing-Order-for-Naloxone-and-Other-Opioid-Reversal-Agents-1.20.26.pdf\">Statewide Standing Order for Naloxone and Other Opioid Reversal Agents<\/a><\/span><\/p>\n<p><strong>Are K-12 schools allowed to possess and administer naloxone to students?<\/strong><\/p>\n<p>The emergency response and procedures for opioid overdose in the school setting are part of the school division\u2019s School Crisis, Emergency Management and Medical Response Plan. The Code of Virginia <a href=\"https:\/\/law.lis.virginia.gov\/vacode\/title54.1\/chapter34\/section54.1-3408\/\">\u00a7 54.1-3408 (X)<\/a> provides the framework for schools to develop policy around naloxone possession and administration in the school setting. This legislation pertains to school nurses, health department personnel assigned to schools, and school board employees that provide health services. They may possess and administer naloxone as long as they have completed a training program pursuant to an oral, written, or standing order.<\/p>\n<p>It is important to note that the Code of Virginia <a href=\"https:\/\/law.lis.virginia.gov\/vacode\/title54.1\/chapter34\/section54.1-3408\/\">\u00a7 54.1-3408 (X)<\/a> does not mandate that schools possess and administer naloxone. School divisions are encouraged to decide whether they want to adopt a naloxone-in-schools policy based on multiple factors including access or location of Emergency Medical Services (EMS) relative to school setting; local data on opioid use\/misuse; School Resource Officers (SROs) possession of naloxone; community and school board feedback; and local resources for sustainability.<\/p>\n<p><strong>How do K-12 schools prepare to possess and administer naloxone?<\/strong><\/p>\n<p>The decision to adopt a naloxone policy in schools is made by the local educational agency (LEA). If an LEA approves naloxone administration by school employees, the <a href=\"https:\/\/www.doe.virginia.gov\/home\/showpublisheddocument\/60889\/638790161829130000\">Best Practices on Naloxone and Other Opioid Antagonists Possession and Administration in Response to a Suspected Opioid Overdose in the School Setting<\/a> may be used by school divisions to assist in developing local school policies in response to suspected opioid overdose.<\/p>\n<p>In order to possess or administer naloxone in the school setting, local school boards must develop and implement policies and procedures for the administration of naloxone in schools and ensure the training of relevant school personnel, pursuant to <a href=\"https:\/\/law.lis.virginia.gov\/vacode\/54.1-3408\">\u00a7 54.1-3408.X<\/a>. The Virginia Department of Behavioral Health and Developmental Services (DBHDS) provides training to school personnel on how to recognize and respond to an opioid overdose emergency with the administration of naloxone.<\/p>\n<p><a href=\"https:\/\/dbhds.virginia.gov\/behavioral-health\/substance-abuse-services\/revive\/\">REVIVE!<\/a> is the name of the DBHDS\u2019 Opioid Overdose and Naloxone Education (OONE) program for the Commonwealth of Virginia. Schools should document training of school personnel on an annual basis and provide the information upon request to VDH. For further information, schools should refer to the <a href=\"https:\/\/www.doe.virginia.gov\/programs-services\/student-services\/specialized-student-support-services\/school-health-services\/school-health-guidance-resources\">Virginia Department of Education School Health webpage<\/a> or contact <a href=\"mailto:opioidreversal@vdh.virginia.gov\">opioidreversal@vdh.virginia.gov<\/a>.<\/p>\n<p><strong>Do I Need to Report on the Use of Naloxone in the School Setting?<\/strong><\/p>\n<p><span data-olk-copy-source=\"MessageBody\">As outlined in the <a href=\"https:\/\/www.doe.virginia.gov\/home\/showpublisheddocument\/60889\/638893951811830000\">Virginia Department of Education's Best Practices on Naloxone and Other Opioid Antagonists (HB 732)<\/a><\/span>, beginning school year 2025-2026, school divisions will report on the administration of opioid antagonists via the School Health Services Data Survey. This mandated data is collected annually and is due via the Single Sign-On Web Systems (SSWS) every June 30th.<\/p>\n<hr \/>\n<p><strong>Additional Resources:<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2023\/11\/Naloxone-Flowchart-for-Community-Partners.pdf\">Naloxone Flowchart for Public K-12 Schools<\/a> - December 12, 2024<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/04\/K-12-naloxone-webinar-2_25_2025-.pdf\">K-12 Public Schools Naloxone Webinar<\/a> - February 25, 2025<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/05\/Opioid-Reversal-Agent-Guidance-for-Public-School-1-1.pdf\">Naloxone Guidance for Public School Divisions<\/a><\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/05\/Opioid-Reversal-Agent-Guidance-for-Private-School-1-1.pdf\">Naloxone Guidance for Private Schools<\/a><\/li>\n<li><a href=\"https:\/\/revive.cieesodu.org\/\"><strong>NEW!<\/strong> Virtual REVIVE! Modules<\/a><\/li>\n<li><a href=\"https:\/\/forms.office.com\/pages\/responsepage.aspx?id=qeUKYsFOoE-GQV2fOGxzCU2AdRZHeWZFr6umeoGLaqNUNUdUSlVISzRWM0Y0NU9GNVhRTDBOTkxKVi4u&amp;route=shorturl\">REVIVE! Certificate of Completion Request Form<\/a><\/li>\n<\/ul>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t<div class=\"sow-accordion-panel\n\t\t\t\t\t\"\n\t\t\t\tdata-anchor-id=\"public-universities\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header-container\" role=\"heading\" aria-level=\"2\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header\" tabindex=\"0\" role=\"button\" id=\"accordion-label-public-universities\" aria-controls=\"accordion-content-public-universities\" aria-expanded=\"false\">\n\t\t\t\t\t\t<div class=\"sow-accordion-title sow-accordion-title-icon-left\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tPublic Universities\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"sow-accordion-open-close-button\">\n\t\t\t\t\t\t\t<div class=\"sow-accordion-open-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf218;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"sow-accordion-close-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf209;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\n\t\t\t<div\n\t\t\t\tclass=\"sow-accordion-panel-content\"\n\t\t\t\trole=\"region\"\n\t\t\t\taria-labelledby=\"accordion-label-public-universities\"\n\t\t\t\tid=\"accordion-content-public-universities\"\n\t\t\t\tstyle=\"display: none;\"\t\t\t>\n\t\t\t\t<div class=\"sow-accordion-panel-border\">\n\t\t\t\t\t<p><span class=\"NormalTextRun SCXW240192699 BCX8\">Public universities are eligible to receive naloxone from <\/span><span class=\"NormalTextRun SCXW240192699 BCX8\">VDH to<\/span><span class=\"NormalTextRun SCXW240192699 BCX8\"> provide to targeted groups, <\/span><span class=\"NormalTextRun SCXW240192699 BCX8\">e.g.<\/span><span class=\"NormalTextRun SCXW240192699 BCX8\">,<\/span><span class=\"NormalTextRun SCXW240192699 BCX8\"> organizations of students in recovery from drug use\/substance use disorder.<\/span><\/p>\n<p>Additional Resources:<\/p>\n<p><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2025\/07\/Virginia-Campus-Forum-5.19.25-Navigation-Training-Requirements-for-RAs.pdf\">Virginia Campus Forum: Navigation Opioid Antagonist Training Requirements for RAs<\/a><\/p>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t<div class=\"sow-accordion-panel\n\t\t\t\t\t\"\n\t\t\t\tdata-anchor-id=\"state-agencies\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header-container\" role=\"heading\" aria-level=\"2\">\n\t\t\t\t\t<div class=\"sow-accordion-panel-header\" tabindex=\"0\" role=\"button\" id=\"accordion-label-state-agencies\" aria-controls=\"accordion-content-state-agencies\" aria-expanded=\"false\">\n\t\t\t\t\t\t<div class=\"sow-accordion-title sow-accordion-title-icon-left\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\tState Agencies\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<div class=\"sow-accordion-open-close-button\">\n\t\t\t\t\t\t\t<div class=\"sow-accordion-open-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf218;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"sow-accordion-close-button\">\n\t\t\t\t\t\t\t\t<span class=\"sow-icon-ionicons\" data-sow-icon=\"&#xf209;\"\n\t\t \n\t\taria-hidden=\"true\"><\/span>\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\n\t\t\t<div\n\t\t\t\tclass=\"sow-accordion-panel-content\"\n\t\t\t\trole=\"region\"\n\t\t\t\taria-labelledby=\"accordion-label-state-agencies\"\n\t\t\t\tid=\"accordion-content-state-agencies\"\n\t\t\t\tstyle=\"display: none;\"\t\t\t>\n\t\t\t\t<div class=\"sow-accordion-panel-border\">\n\t\t\t\t\t<p><a href=\"https:\/\/lis.virginia.gov\/cgi-bin\/legp604.exe?ses=241&amp;typ=bil&amp;val=hb342\">House Bill 342<\/a> was passed in the 2024 General Assembly session and is effective July 1, 2024. HB342 requires state agencies to possess naloxone or other opioid antagonists used for overdose reversal to a person who is believed to be experiencing or about to experience a life-threatening opioid overdose and permits employees of any state agency to possess and administer naloxone or other opioid antagonists. See the statewide procurement and distribution plan below:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/08\/Plan-for-the-Procurement-and-Distribution-of-Opioid-Reversal-Agents-to-State-Agencies.pdf\">Plan-for-the-Procurement-and-Distribution-of-Opioid-Reversal-Agents-to-State-Agencies<\/a> (Revised September 26, 2024)<\/li>\n<\/ul>\n\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t<\/div>\n\t\t<\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div><div id=\"pg-300-1\"  class=\"panel-grid panel-has-style\" ><div class=\"subhead panel-row-style panel-row-style-for-300-1\" id=\"Naloxone-and-Test-Strips\" ><div id=\"pgc-300-1-0\"  class=\"panel-grid-cell\" ><div id=\"panel-300-1-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"5\" ><div class=\"separator panel-widget-style panel-widget-style-for-300-1-0-0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<\/div>\n<\/div><\/div><\/div><div id=\"panel-300-1-0-1\" class=\"so-panel widget widget_sow-editor panel-last-child\" data-index=\"6\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t><h3 class=\"widget-title\">Naloxone and Test Strips Request Process for Eligible Community Partners<\/h3>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><strong><span class=\"TextRun SCXW206286479 BCX8\" lang=\"EN\" xml:lang=\"EN\" data-contrast=\"auto\"><span class=\"NormalTextRun SCXW206286479 BCX8\">Additional Resources:<\/span><\/span><\/strong><span class=\"EOP SCXW206286479 BCX8\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335559740&quot;:276}\">\u00a0<\/span><\/p>\n<ul>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/Pharmacy-Partner-Hub-User-Guide-August-2025.pdf\">Pharmacy Partner Hub User Guide<\/a> - Revised August 2025<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/05\/Pharmacy-Partner-Hub-FAQ-5.30.25.pdf\">Pharmacy Partner Hub FAQ<\/a> - Revised May 2025<\/li>\n<li><a href=\"https:\/\/www.vdh.virginia.gov\/content\/uploads\/sites\/219\/2024\/07\/Registration-and-Order-Instructions-for-Pharmacy-Partner-Hub.pdf\">Registration and Order Instructions for Pharmacy Partner Hub<\/a> - Revised July 2024<\/li>\n<\/ul>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div><div id=\"pg-300-2\"  class=\"panel-grid panel-no-style\" ><div id=\"pgc-300-2-0\"  class=\"panel-grid-cell\" ><div id=\"panel-300-2-0-0\" class=\"so-panel widget widget_sow-editor panel-first-child\" data-index=\"7\" ><div class=\"steps panel-widget-style panel-widget-style-for-300-2-0-0\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t><h3 class=\"widget-title\"><b>Step 1:<\/b> Apply<\/h3>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><span class=\"steps-button\"><a href=\"https:\/\/pharmacypartnerprograms.vdh.virginia.gov\/cph\/r\/web\/naloxone-org-registration\/home?session=16854987139612\">Use this form to APPLY<\/a><\/span> if<span class=\"TextRun SCXW52533631 BCX8\" lang=\"EN-US\" xml:lang=\"EN-US\" data-contrast=\"none\"><span class=\"NormalTextRun SCXW52533631 BCX8\">\u00a0it is the first time your organization <\/span><span class=\"NormalTextRun SCXW52533631 BCX8\">is requesting naloxone,<\/span> <span class=\"NormalTextRun SCXW52533631 BCX8\">if your organization\u2019s agreement with VDH has expired<\/span><span class=\"NormalTextRun SCXW52533631 BCX8\">, OR if you have an active agreement with VDH and h<\/span><span class=\"NormalTextRun SCXW52533631 BCX8\">ave not yet registered your organization in the Pharmacy Partner Hub<\/span><span class=\"NormalTextRun SCXW52533631 BCX8\">.<\/span><span class=\"NormalTextRun SCXW52533631 BCX8\"> Once all signatures are obtained and the agreement is executed, the organization <\/span><span class=\"NormalTextRun SCXW52533631 BCX8\">is responsible for<\/span><span class=\"NormalTextRun SCXW52533631 BCX8\"> ensuring the agreement is updated before <\/span><span class=\"NormalTextRun SCXW52533631 BCX8\">expiration<\/span><span class=\"NormalTextRun SCXW52533631 BCX8\"> date.<\/span><\/span><span class=\"EOP SCXW52533631 BCX8\" data-ccp-props=\"{&quot;201341983&quot;:0,&quot;335557856&quot;:15856113,&quot;335559738&quot;:264,&quot;335559739&quot;:396,&quot;335559740&quot;:259}\">\u00a0<\/span><\/p>\n<p>To renew an existing agreement, please contact\u00a0<a href=\"mailto:opioidreversal@vdh.virginia.gov\">opioidreversal@vdh.virginia.gov<\/a>.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"panel-300-2-0-1\" class=\"so-panel widget widget_sow-editor\" data-index=\"8\" ><div class=\"steps panel-widget-style panel-widget-style-for-300-2-0-1\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t><h3 class=\"widget-title\"><b>Step 2:<\/b> Order<\/h3>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><span class=\"NormalTextRun SCXW85025008 BCX8\">\u00a0<\/span><span class=\"NormalTextRun SCXW85025008 BCX8\">If you <\/span><span class=\"NormalTextRun SCXW85025008 BCX8\">have an active agreement and have registered in the Pharmacy Partner Hub, l<\/span><span class=\"NormalTextRun SCXW85025008 BCX8\">og in to your Pharmacy Partner Hub account to order naloxone and test strips:<\/span><\/p>\n<p><span class=\"steps-button\" style=\"margin-top: 5px;\"><a href=\"https:\/\/pharmacypartnerprograms.vdh.virginia.gov\/cph\/r\/web\/pharmacy-partner-hub\/login?p9999_app_id=101&amp;session=8349828898074&amp;cs=14SlxuXwEZ9v2haEG19RZYoNc2PFaF0qCH7HomYrraXISuIsHZTIn2A0lA0u5cHv8LrovqS9iDYotcCu-TRiJTw\">Pharmacy Partner Hub Login<\/a><\/span><\/p>\n<p><span class=\"NormalTextRun SCXW194032850 BCX8\">If you are a Local Health District, please use WebVision<\/span><span class=\"NormalTextRun SCXW194032850 BCX8\">\u00a0to order naloxone and test strips.<\/span><\/p>\n<p><span class=\"steps-button\" style=\"margin-top: 5px;\"><a href=\"https:\/\/vision.vdh.virginia.gov\/apexvisprod\/f?p=WV_SSO:LOGIN_DESKTOP\">WebVision Login<\/a><\/span><\/p>\n<p>If you are unsure whether your organization has an executed agreement or if an agreement is still active, please contact\u00a0<a href=\"mailto:opioidreversal@vdh.virginia.gov\">opioidreversal@vdh.virginia.gov<\/a>.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"panel-300-2-0-2\" class=\"so-panel widget widget_sow-editor\" data-index=\"9\" ><div class=\"steps panel-widget-style panel-widget-style-for-300-2-0-2\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t><h3 class=\"widget-title\"><b>Step 3:<\/b> Return<\/h3>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p><span class=\"steps-button\"><a href=\"https:\/\/redcap.vdh.virginia.gov\/redcap\/surveys\/?s=DA3NPWD38Y\">Please use this form to RETURN<\/a><\/span> expired, unused, or damaged naloxone to the Virginia Department of Health. Partner organizations are required to return expired, unused, or damaged naloxone kits and may not distribute them to other organizations.<\/p>\n<\/div>\n<\/div><\/div><\/div><div id=\"panel-300-2-0-3\" class=\"so-panel widget widget_sow-editor\" data-index=\"10\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-editor so-widget-sow-editor-base\"\n\t\t\t\n\t\t>\n<div class=\"siteorigin-widget-tinymce textwidget\">\n\t<p style=\"text-align: center;\">Contact Us:\u00a0<a href=\"mailto:OpioidReversal@vdh.virginia.gov\">OpioidReversal@vdh.virginia.gov<\/a><\/p>\n<\/div>\n<\/div><\/div><div id=\"panel-300-2-0-4\" class=\"so-panel widget widget_sow-button panel-last-child\" data-index=\"11\" ><div\n\t\t\t\n\t\t\tclass=\"so-widget-sow-button so-widget-sow-button-flat-cf5937166751-300\"\n\t\t\t\n\t\t><div class=\"ow-button-base ow-button-align-center\"\n>\n\t\t\t<a\n\t\t\t\t\thref=\"https:\/\/forms.office.com\/Pages\/ResponsePage.aspx?id=qeUKYsFOoE-GQV2fOGxzCVQa_4qmo8JAt1tYKs5PpGlUMkEyWlJZRTZRUEJMS0hBME0zR0VWRFIzUC4u\"\n\t\t\t\t\tclass=\"sowb-button ow-icon-placement-left ow-button-hover\" \t>\n\t\t<span>\n\t\t\t\n\t\t\tNaloxone Distribution Program Office Hours Interest Form\t\t<\/span>\n\t\t\t<\/a>\n\t<\/div>\n<\/div><\/div><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Harm Reduction Test Strips Order Naloxone and Test Strips Naloxone Distribution Newsletters High-Impact (No-Cost) Naloxone Distribution\u00a0\u00a0 Virginia Department of Health (VDH) and the Virginia Department of Behavioral Health and Developmental Services (DBHDS) share the common goal of increasing naloxone access for all Virginians. Due to limited resources, VDH is prioritizing high-risk individuals to receive no-cost [&hellip;]<\/p>\n","protected":false},"author":52,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","inline_featured_image":false,"footnotes":""},"tags":[],"class_list":["post-300","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Naloxone Distribution to Community Partners - Naloxone<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Naloxone Distribution to Community Partners - Naloxone\" \/>\n<meta property=\"og:description\" content=\"Harm Reduction Test Strips Order Naloxone and Test Strips Naloxone Distribution Newsletters High-Impact (No-Cost) Naloxone Distribution\u00a0\u00a0 Virginia Department of Health (VDH) and the Virginia Department of Behavioral Health and Developmental Services (DBHDS) share the common goal of increasing naloxone access for all Virginians. Due to limited resources, VDH is prioritizing high-risk individuals to receive no-cost [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/\" \/>\n<meta property=\"og:site_name\" content=\"Naloxone\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-02T17:14:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/naloxone-distribution-to-community-partners\\\/\",\"url\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/naloxone-distribution-to-community-partners\\\/\",\"name\":\"Naloxone Distribution to Community Partners - Naloxone\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/#website\"},\"datePublished\":\"2023-09-07T16:14:27+00:00\",\"dateModified\":\"2026-04-02T17:14:53+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/naloxone-distribution-to-community-partners\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/naloxone-distribution-to-community-partners\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/naloxone-distribution-to-community-partners\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Naloxone Distribution to Community Partners\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/#website\",\"url\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/\",\"name\":\"Naloxone\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.vdh.virginia.gov\\\/naloxone\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Naloxone Distribution to Community Partners - Naloxone","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/","og_locale":"en_US","og_type":"article","og_title":"Naloxone Distribution to Community Partners - Naloxone","og_description":"Harm Reduction Test Strips Order Naloxone and Test Strips Naloxone Distribution Newsletters High-Impact (No-Cost) Naloxone Distribution\u00a0\u00a0 Virginia Department of Health (VDH) and the Virginia Department of Behavioral Health and Developmental Services (DBHDS) share the common goal of increasing naloxone access for all Virginians. Due to limited resources, VDH is prioritizing high-risk individuals to receive no-cost [&hellip;]","og_url":"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/","og_site_name":"Naloxone","article_modified_time":"2026-04-02T17:14:53+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/","url":"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/","name":"Naloxone Distribution to Community Partners - Naloxone","isPartOf":{"@id":"https:\/\/www.vdh.virginia.gov\/naloxone\/#website"},"datePublished":"2023-09-07T16:14:27+00:00","dateModified":"2026-04-02T17:14:53+00:00","breadcrumb":{"@id":"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.vdh.virginia.gov\/naloxone\/naloxone-distribution-to-community-partners\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.vdh.virginia.gov\/naloxone\/"},{"@type":"ListItem","position":2,"name":"Naloxone Distribution to Community Partners"}]},{"@type":"WebSite","@id":"https:\/\/www.vdh.virginia.gov\/naloxone\/#website","url":"https:\/\/www.vdh.virginia.gov\/naloxone\/","name":"Naloxone","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.vdh.virginia.gov\/naloxone\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/pages\/300","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/users\/52"}],"replies":[{"embeddable":true,"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/comments?post=300"}],"version-history":[{"count":22,"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/pages\/300\/revisions"}],"predecessor-version":[{"id":777,"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/pages\/300\/revisions\/777"}],"wp:attachment":[{"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/media?parent=300"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.vdh.virginia.gov\/naloxone\/wp-json\/wp\/v2\/tags?post=300"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}